FENOFIBRATE 145 mg/1 (Fenofibrate TABLET) 145 mg/1

Fenofibrate 145 mg tablets are a medication used to manage lipid levels in the blood. This oral tablet helps reduce triglycerides and increase HDL cholesterol, supporting cardiovascular health.

Strength

145 mg/1

Pack Size

30 TABLET in 1 BLISTER PACK (0615-8530-39)

Manufacturer / TM Owner

NCS HealthCare of KY, LLC dba Vangard Labs

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fenofibrate 145 mg tablets are commonly used to treat high levels of triglycerides in the blood. This medication is often prescribed to help lower triglyceride levels and raise HDL (good) cholesterol. Fenofibrate is used as part of a comprehensive treatment plan that includes diet and exercise to manage lipid levels and support heart health.

Side Effects

Common effects of Fenofibrate 145 mg tablets may include gastrointestinal discomfort, such as nausea or stomach pain. Some users may experience muscle pain or weakness. These effects vary among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

Fenofibrate 145 mg tablets should be taken as directed by a healthcare provider. It is important to follow the prescribed dosage and not to exceed it. Patients with liver or kidney disease should consult their healthcare provider before taking this medication. Regular monitoring of liver function may be recommended.

Avoid Interactions

Fenofibrate 145 mg tablets may interact with other medications, including blood thinners, statins, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited while taking this medication.

Frequently Asked Questions

Fenofibrate 145 mg tablets are used to lower triglyceride levels and increase HDL cholesterol in the blood, supporting cardiovascular health.

Fenofibrate 145 mg tablets are taken orally, usually with a meal, as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, nausea, stomach pain, and muscle pain or weakness.

It is recommended to limit alcohol consumption while taking Fenofibrate 145 mg tablets to avoid potential interactions.

Patients with liver or kidney disease should consult their healthcare provider before taking Fenofibrate 145 mg tablets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.